Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2011-07-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ReceptIVFity & Immunology in ART
NCT06709976
Pre-washing the Catheter With a Culture Medium Before Intrauterine Insemination
NCT04736459
Clinical Evaluation of a Tubal Selective Delivery System
NCT05775913
The Microbiome of Infertile Couples and Its Effect on Their Reproductive Outcomes
NCT03420859
Utility of Fallopian Tube Cocultures in Assisted Reproductive Technology
NCT02341339
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm A
Arm A performs a CAT test to study tubal factor causes
CAT test
A CAT test is performed in order to diagnose tubal factor causes
Arm B
In Arm B a histerosalpingography is performed.
Histerosalpingography
A Histerosalpingography is performed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CAT test
A CAT test is performed in order to diagnose tubal factor causes
Histerosalpingography
A Histerosalpingography is performed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* FSH \< 12.
* Treatment intrauterine insemination
Exclusion Criteria
* Thyroid disease
* Severe male factor
* Policystic ovarian syndrome
* Previous abdominal or uterine surgery
* Prevous abdominal or genital infections
* Uterine myomas
* Hidrosalpinx
* Uterine congenital abnormalities
18 Years
38 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Valenciano de Infertilidad, IVI VALENCIA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
IVI Valencia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IVI Valencia
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VLC-JD-0904-025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.